Antibody Directory

Glowell standards to revolutionise calibration and validation of experimental data from a wide range of light measurement systems

In November 2004 Lux Biotechnology launched a drug discovery technology based on moulds that glow in the dark

In 14 November 2005 Lux Biotechnology announced that Jim Brown, the exiting senior executive of GE Healthcare, was joining the company as chairman of the board of directors

In February 2004 Lux biotechnology finalised patent filing for its novel biosensor and assay based on luminescent and fluorescent filamentous fungi

Lux Biotechnology, a developer of luminescence and fluorescence technologies, has a new partnership with UVP for the distribution of low light imaging standards (LLIS) in North America and Europe

Lux Assure has been given a grant by the Technology Strategy Board (TSB) for the development of a technology for corrosion mitigation in the oil and gas industry.

Following the success of the Glowell range of luminescent standards, Lux Biotechnology is branching out into fluorescent standards, offering a high quality and versatile range of products

Lux screens offer an effective platform for high throughput screening and give extraordinary insight into possible mode of action and potency of drug candidates

In January 2004 Lux Biotechnology signed an exclusive distribution agreement for the UK and the Republic of Ireland with Prolume for its Nanolight products

Lux biotechnology announces the world premiere of The Paper Nautilus, the new work from performing arts companies Theatre Cryptic and Paragon Ensemble

Lux DS and the Centre for Clinical Innovations at the University of Dundee have received a grant for the development of the Carivis photonics-based device for the assessment of dental disease.

Lux Innovate has been awarded a GBP70,000 Smart grant from Scottish Enterprise to investigate a detection method for chemical additives in the oil industry.

20 March 2009 - Lux Innovate has appointed Dr Keith Winton as chairman to its board of directors.

Specialist developer of light based detection technologies has announced the appointment of Bryan Smith as chief operating officer of the company

The award recognises the results achieved by Lux's pioneering research and development and the company's contribution to enhancing the reputation of the Scottish biotechnology industry

Lux biotechnology has joined forces with experts from across Europe to investigate the disturbance of our internal biological clock

Apogee Technology (PINKSHEETS: ATCS), a life sciences company focused on the development of vaccine and drug delivery systems, announced publication of an article on its intradermal immunization approach in the Online Early Edition of PNAS (the Proceedings of the National Academy of Sciences of the USA).

In her most recent study of possible triggers of cancer among northern New England residents, Dartmouth epidemiologist Margaret R. Karagas, Ph.D., and her team identified an enhanced risk to the bladders of patients taking drugs that suppress the immune system.

An experimental drug, LX211 (LUVENIQ™; oral voclosporin), may become the first approved oral treatment capable of modifying the course of uveitis, a group of serious eye conditions inevitably associated with either severe vision loss or substantial morbidity from steroid use.

Almost half of adults surveyed in Summer 2009 in Hong Kong (45%) say they would take up free swine flu vaccination. However, this figure drops to around 1 in 7 (15%) if the price they have to pay for the vaccine reaches $HK200 (16 pounds; 17 euros; 26 dollars). In the absence of proved efficacy and safety, the figure decreases to less than 1 in 20 (5%), according to one of the first studies on behavioural intentions and A/H1N1 vaccination, published on

Antigenics (NASDAQ: AGEN) announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA. Data were presented in Sunrise Session #6: Immunotherapy: Current Status of Clinical Trials on Saturday, October 24.

Capture Billing and Consulting, Inc., a medical billing and coding company, would like to help keep healthcare professionals informed and up to date on the latest coding and billing specifications and regulations. With its release of the "Medical Billing Minute" video, Capture Billing hopes to educate physicians on how to code for the H1N1 Swine Flu Vaccine. The H1N1 virus and resulting epidemic is currently one of our nation's top health concerns.

A study about why African American seniors do or do not get influenza vaccinations finds that many of them do not have accurate and complete information about the flu itself, the safety and efficacy of the inoculations, and the ease and necessity of getting the shots.

Health Minister Leona Aglukkaq and Canada's Chief Public Health Officer, Dr. David Butler-Jones, announced today that the Government of Canada had secured additional unadjuvanted H1N1 flu vaccine from Australia. "The Government wants pregnant women across the country to have access to unadjuvanted vaccine as soon as possible," said Minister Aglukkaq.

Temptime Corporation announced today that it will donate its Vaccine Vial Monitors (VVMs) to the World Health Organization (WHO) to monitor potential heat damage of H1N1 vaccines to be distributed by WHO to developing countries most in need. "There are challenges related to the rapid distribution of the H1N1 vaccine during a pandemic situation, including the need to maintain proper temperature control of the vaccines from the manufacturer to the recipient.

Doctors from across the state came together this past weekend to advance the practice of modern medicine for the state and its patients by adopting numerous new California Medical Association policies. In some of their most noteworthy decisions, physician leaders declared that all health care workers should be vaccinated for H1N1, health care reform should cover the uninsured and more public outreach should be conducted to combat obesity.

President Barack Obama declared a state of emergency as the number of swine flu cases soars and vaccine production doesn't keep up with demand. The

Aging In Place Is Not So Easy Kaiser Health News "Aging in Place" is the popular rallying cry in the senior community. But living at home is not so easy, either for the frail elderly or younger people with disabilities. Interestingly enough, the reasons may have more to do with social issues than medical concerns (Howard Gleckman, 10/26).

Supplies of the H1N1 (swine flu) vaccine are steadily increasing in the U.S. and should soon be more widely accessible in the next two weeks, the CDC said on Tuesday, CQ HealthBeat reports. During a press briefing, CDC Director Thomas Frieden said that 22.4 million vaccine doses are now available for states to order (Norman, 10/27). "We're beginning to get to significant increases in the availability," Frieden said.

The Government of Canada today provided important guidance on how to reduce the spread of the H1N1 flu virus on planes, trains, ferries and inter-city buses. "Canadians want to know how the H1N1 flu virus affects their regular travel " said Health Minister Leona Aglukkaq.

Recognizing that the H1N1 virus is a pandemic and a public health emergency, the American Nurses Association (ANA) is urging all registered nurses to get the H1N1 vaccine to protect themselves, their families, and the patients they serve.

New research from Queen Mary, University of London and Harvard Medical School has revealed precisely why taking fish oils can help with conditions like rheumatoid arthritis. In a paper published in Nature*, researchers describe how the body converts an ingredient found in fish oils into another chemical called Resolvin D2 and how this chemical reduces the inflammation that leads to a variety of diseases.

Hospitals across the country are overwhelmed "as waves of flu patients arrive at their doors, doubling their emergency room volume," USA Today reports. "Just as significant is the effect on intensive care units: A relatively small number of flu patients are requiring intensive care, but some are so ill they will need round-the-clock care for weeks.

President Barack Obama declared H1N1 a national emergency this weekend, a status that will give the federal government greater flexibility and authority to contain the pandemic. But the current shortage of H1N1 vaccine underscores the severe lack of U.S. preparedness in responding to pandemics, whether through natural disease transmission or manmade bioterrorist attacks, according to a new video from the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism.

Insoluble dietary fibre, or roughage, not only keeps you regular, say Australian scientists, it also plays a vital role in the immune system, keeping certain diseases at bay. The indigestible part of all plant-based foods pushes its way through most of the digestive tract unchanged, acting as a kind of internal broom. When it arrives in the colon, bacteria convert it to energy and compounds known as 'short chain fatty acids'.

Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain. Research published in BioMed Central's open access journal, Arthritis Research & Therapy found that inflammation is associated with heightened pain sensitivity at joint sites, whereas increased sleep problems are associated with heightened pain sensitivity at both joint and non-joint sites.

"More than 22 million doses of swine flu vaccine are available now, and most Americans should soon find it easier to get their dose, U.S. health officials said Tuesday, " according to The Associated Press/The Washington Post.

One of the first studies on behavioral intentions and A/H1N1 vaccination is just published on bmj.com. It reports that almost half of adults surveyed in summer 2009 in Hong Kong (45 percent) say they would take up free swine flu vaccination. However, this figure drops to around 1 in 7 (15 percent) if the price they have to pay for the vaccine reaches $26 (Â£16; 17 euros; $HK200). In the absence of proved efficacy and safety, the figure decreases to less than 1 in 20 (5 percent).

Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas.

As part of a "major push to convince the United States to maintain government spending on worldwide health initiatives, despite the financial crisis and a soaring U.S. budget deficit," the Bill & Melinda Gates Foundation is urging U.S. policymakers to commit to cutting "the number of child deaths each year, from 9 million to 5 million" by 2025,

Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study. The finding provides an argument in favor of flu vaccination during pregnancy, researchers say, because it suggests that the immune systems in depressed pregnant women are not functioning typically.

TheMedGuru

New antibody found to stop internal bleeding
TheMedGuru
by Neharika Sabharwal - October 29, 2009 Oklahoma City, October 28 -- Researchers in US have discovered antibodies that prevent the destruction of blood ...

BBC News

Antibody 'fixes internal bleeds'
BBC News
Scientists say they have discovered an antibody that could minimise the major internal bleeding seen in traumas like bullet wounds and car crashes. ...
New antibody to save severely-injured patientsPRESS TV
Oklahoma Medical Research Foundation scientists tout antibody as a lifesaverNewsOK.com
Study: Antibody Stops Protein That Causes Internal BleedingAHN
Science Daily (press release) -United Press International -india-server.com
all 51 news articles »

The Money Times

Genmab says gets FDA approval for Arzerra
Reuters
"The approval of Arzerra marks a key milestone for Genmab as it is our first antibody to reach the market," Genmab Chief Executive Lisa Drakeman said in a ...
FDA gives GlaxoSmithKline green light for leukemia drug ArzerraBizjournals.com
GSK and Genmab's Arzerra approved by FDA for CLLPharma Times
Genmab wins $23M on blockbuster cancer approvalFierceBiotech
Genetic Engineering News (press release) -HemOncToday -MedPage Today
all 112 news articles »

Virdante Series A Brings in $47M to Boost New Antibody Program
Therapeutics Daily (press release) (registration)
based company has been working over the past year to improve the anti-inflammatory activity of antibody-based drugs that treat autoimmune and inflammatory ...
Virdante Pharmaceuticals Secures Funding to Improve Antibody-based ...Business Wire (press release)
Virdante Pharma Lands $30M in A Round to Combat InflammationXconomy
Virdante Pharmaceuticals boosts first round to $47MMass High Tech
Boston Globe -FierceBiotech
all 13 news articles »

Sun2Surf

Antibody protects animals against Nipah virus
Reuters
CHICAGO, Oct 29 (Reuters) - A new antibody treatment protected animals that had been exposed to the deadly Nipah virus, raising hopes for a treatment for ...
Nipah research leads to hopes for Hendra cureThe Australian
Hendra-like virus identified as potential threatABC Online

all 10 news articles »

15-20% Puneites may be immune to H1N1: NIV
Times of India
He said there were two types of immune responses antibody-mediated and cell-mediated. "Antibodies are special proteins that react specifically with a ...

and more »

Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of ...
Reuters
CDX-1307 is a fusion protein composed of a mannose receptor-specific human monoclonal antibody genetically fused with the hCG-β antigen. ...
Celldex cancer drug candidate returns positive newsMass High Tech

all 17 news articles »

Scientists Propose New Explanation For Flu Virus Antigenic Drift
Science Daily (press release)
According to the prevailing theory, drift occurs as the virus is passed from person to person and is exposed to differing antibody attacks at each stop. ...

and more »

Micromet inks $475M antibody deal with Sanofi
FierceBiotech
In a big endorsement of Micromet's approach to developing antibodies for cancer, Sanofi-Aventis has signed off on a $475 million deal that starts small but ...
Another 'BiTE' as Micromet Inks Potential €320M Sanofi AllianceBioWorld Online
Sanofi, Micromet To Collaborate On BiTE AntibodyNASDAQ
Micromet signs deal worth $477MBizjournals.com
PharmiWeb.com (press release) -Reuters -Trading Markets (press release)
all 19 news articles »